Virus-host Interactions during Hepatitis C Virus Entry-Implications for Pathogenesis and Novel Treatment Approaches

被引:1
|
作者
Joachim Lupberger
Mirjam B. Zeisel
Anita Haberstroh
Eva K. Schnober
Sophie Krieger
Eric Soulier
Christine Thumann
Cathy Royer
Samira Fafi-Kremer
Catherine Schuster
Franoise Stoll-Keller
Hubert E. Blum
Thomas F. Baumert
机构
[1] F-67000 Strasbourg France
[2] F-67000 Strasbourg France Service d’Hépatogastroentérologie H?pitaux Universitaires de Strasbourg Strasbourg France Department of Medicine II University of Freiburg Germany
[3] Inserm U748 H?pitaux Universitaires de Strasbourg Université Louis Pasteur 3 Rue Koeberle Department of Medicine II University of Freiburg Department of Medicine II University of Freiburg
[4] Germany
[5] Inserm U748 H?pitaux Universitaires de Strasbourg Université Louis Pasteur 3 Rue Koeberle
关键词
Hepatitis C virus; Viral entry; Entry inhibitor; Neutralizing antibodies;
D O I
暂无
中图分类号
R512.6 [病毒性肝炎];
学科分类号
100401 ;
摘要
Hepatitis C virus (HCV) is a member of the Flaviviridae family and causes acute and chronic hepatitis. Chronic HCV infection may result in severe liver damage including liver cirrhosis and hepatocellular carcinoma. The liver is the primary target organ of HCV, and the hepatocyte is its primary target cell. Attachment of the virus to the cell surface followed by viral entry is the first step in a cascade of interactions between the virus and the target cell that is required for successful entry into the cell and initiation of infection. This step is an important determinant of tissue tropism and pathogenesis; it thus represents a major target for antiviral host cell responses, such as antibody-mediated virus neutralization. Following the development of novel cell culture models for HCV infection our understanding of the HCV entry process and mechanisms of virus neutralization has been markedly advanced. In this review we summarize recent developments in the molecular biology of viral entry and its impact on pathogenesis of HCV infection, development of novel preventive and therapeutic antiviral strategies.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 50 条
  • [41] Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment
    Carlo Visco
    Silvia Finotto
    World Journal of Gastroenterology, 2014, (32) : 11054 - 11061
  • [42] Cost-effectiveness of novel treatment of hepatitis C virus in Lebanese patients
    Soumana C. Nasser
    Hanine Mansour
    Tatiana Abi Nader
    Mirna Metni
    International Journal of Clinical Pharmacy, 2018, 40 : 693 - 699
  • [43] Landscape of protein-protein interactions during hepatitis C virus assembly and release
    Matthaei, Alina
    Joecks, Sebastian
    Frauenstein, Annika
    Bruening, Janina
    Bankwitz, Dorothea
    Friesland, Martina
    Gerold, Gisa
    Vieyres, Gabrielle
    Kaderali, Lars
    Meissner, Felix
    Pietschmann, Thomas
    Das, Saumitra
    MICROBIOLOGY SPECTRUM, 2024, 12 (02):
  • [44] Cost-effectiveness of novel treatment of hepatitis C virus in Lebanese patients
    Nasser, Soumana C.
    Mansour, Hanine
    Nader, Tatiana Abi
    Metni, Mirna
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 693 - 699
  • [45] Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment
    Visco, Carlo
    Finotto, Silvia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (32) : 11054 - 11061
  • [46] Identification of Interactions in the E1E2 Heterodimer of Hepatitis C Virus Important for Cell Entry
    Maurin, Guillemette
    Fresquet, Judith
    Granio, Ophelia
    Wychowski, Czeslaw
    Cosset, Francois-Loic
    Lavillette, Dimitri
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (27) : 23865 - 23876
  • [47] Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment?
    Arshad, M.
    El-Kamary, S. S.
    Jhaveri, R.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) : 229 - 236
  • [48] Dynamics of hepatitis C virus quasispecies turnover during interferon-α treatment
    von Wagner, M
    Lee, JH
    Rüster, B
    Kronenberger, B
    Sarrazin, C
    Roth, WK
    Zeuzem, S
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 413 - 422
  • [49] New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin
    Bizollon, T
    Ducerf, C
    Trepo, C
    JOURNAL OF HEPATOLOGY, 1995, 23 : 22 - 25
  • [50] Hepatitis C Virus-Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes
    Le, Duong Hoang Huy
    Kanokudom, Sitthichai
    Nguyen, Ha Minh
    Yorsaeng, Ritthideach
    Honsawek, Sittisak
    Vongpunsawad, Sompong
    Poovorawan, Yong
    VIRUSES-BASEL, 2024, 16 (12):